Publications
Detailed Information
Comparison of upper airway patency in patients with mild obstructive sleep apnea during dexmedetomidine or propofol sedation: a prospective, randomized, controlled trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, Hyun-Jung | - |
dc.contributor.author | Kim, Eun-Young | - |
dc.contributor.author | Hwang, Jung-Won | - |
dc.contributor.author | Do, Sang-Hwan | - |
dc.contributor.author | Na, Hyo-Seok | - |
dc.date.accessioned | 2018-11-15T06:41:22Z | - |
dc.date.available | 2018-11-15T15:42:27Z | - |
dc.date.issued | 2018-09-05 | - |
dc.identifier.citation | BMC Anesthesiology, 18(1):120 | ko_KR |
dc.identifier.issn | 1471-2253 | - |
dc.identifier.uri | https://hdl.handle.net/10371/143547 | - |
dc.description.abstract | Background
In addition to propofol, dexmedetomidine is a suitable alternative for intraoperative sedation in procedures requiring regional anesthesia. To date, however, little is known about the influences of each drug on upper airway patency. Accordingly, the authors investigated differences between dexmedetomidine and propofol sedation in the occurrence of upper airway obstruction and requirements for airway intervention in patients with mild obstructive sleep apnea. Methods Patients with an apnea/hypopnea index of 5–14/h according to Watch-PAT 200 analysis were enrolled in this study. Spinal anesthesia was routinely performed for surgery. Intraoperative sedation was initiated using either dexmedetomidine or propofol infusion at a level of modified observers assessment of alertness/sedation scale 3. The primary outcome was the proportion of patients exhibiting signs of upper airway obstruction. A sign of upper airway obstruction was defined as no detection of end-tidal carbon dioxide for at least 10s despite respiratory efforts. Results A total of 50 patients were included in the final analysis (dexmedetomidine [n = 26]; propofol [n = 24]). During the intraoperative sedation period, there was a significantly lower proportion of patients exhibiting signs of upper airway obstruction in the dexmedetomidine group than in the propofol group (11.5% vs. 41.7%, P = 0.035). An artificial airway was inserted in 1 patients (3.8%) and 5 patient (20.8%) in the dexmedetomidine and propofol groups, respectively (P = 0.093). Conclusion Dexmedetomidine sedation was associated with a lower incidence of upper airway obstruction than propofol sedation in patients with mild obstructive sleep apnea. Trial registration number Clinical trials.gov ( NCT02993718 ): Retrospectively registered. | ko_KR |
dc.description.sponsorship | This work was supported by a grant [No. 02–2014-044] from the research fund of Seoul National University Bundang Hospital, South Korea. The role of the funding body is none. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BioMed Central | ko_KR |
dc.subject | Dexmedetomidine | ko_KR |
dc.subject | Obstructive sleep apnea | ko_KR |
dc.subject | Propofol | ko_KR |
dc.subject | Sedation | ko_KR |
dc.title | Comparison of upper airway patency in patients with mild obstructive sleep apnea during dexmedetomidine or propofol sedation: a prospective, randomized, controlled trial | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 신현정 | - |
dc.contributor.AlternativeAuthor | 김은영 | - |
dc.contributor.AlternativeAuthor | 황정원 | - |
dc.contributor.AlternativeAuthor | 도상환 | - |
dc.contributor.AlternativeAuthor | 나효석 | - |
dc.identifier.doi | 10.1186/s12871-018-0586-5 | - |
dc.language.rfc3066 | en | - |
dc.rights.holder | The Author(s). | - |
dc.date.updated | 2018-09-09T03:21:12Z | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.